Hypertensive Retinopathy

Retinal arterioles are the only part of the human vasculature that can be directly visualized non-invasively, making the fundus exam a uniquely accessible window into systemic vascular health. Chronic arterial hypertension produces progressive arteriolar wall changes, while acute, severe hypertension can overwhelm retinal vascular autoregulation entirely.

Hypertensive retinopathy is the spectrum of retinal vascular changes caused by systemic hypertension, ranging from mild chronic arteriolar changes to malignant hypertensive retinopathy, a sight- and life-threatening emergency.

Chronic hypertension causes arteriolar medial hypertrophy, hyaline degeneration, and intimal thickening, producing generalized/focal arteriolar narrowing and arteriovenous nicking at crossing points. Retinal vessel tortuosity on OCT angiography correlates with hypertensive retinopathy severity graded by traditional clinical classification, supporting OCTA as an objective adjunct to fundus grading.¹

In malignant (acute, severe) hypertension, breakdown of retinal vascular autoregulation causes fibrinoid arteriolar necrosis, blood-retinal barrier disruption, and ischemia — producing hemorrhages, cotton-wool spots, macular star exudates, and disc edema. Rarely, the vascular dysregulation extends to the optic nerve's blood supply, causing non-arteritic anterior ischemic optic neuropathy (NAION).³

Chronic, mild-to-moderate hypertensive retinopathy is usually asymptomatic, found incidentally on fundus exam. Malignant hypertensive retinopathy can present with blurred vision, field defects, or sudden vision loss, typically with systemic signs of a hypertensive emergency (headache, chest pain, altered mental status, focal neurologic deficits).

Key differentials include diabetic retinopathy (may coexist; distinguished by microaneurysm/neovascularization pattern), retinal vein occlusion (acute onset, different hemorrhage distribution), radiation retinopathy (exposure history), ocular ischemic syndrome, and papilledema from other causes of raised intracranial pressure (bilateral disc edema without the exudative retinal vascular changes seen in malignant hypertension).

Grading traditionally uses the Keith-Wagener-Barker or Scheie clinical classification systems based on fundus appearance. Quantitative OCTA vessel tortuosity metrics are an emerging objective adjunct correlating with these clinical grades.¹ In malignant hypertensive retinopathy, OCT-based macular structural assessment at presentation correlates with visual outcomes, making it a useful baseline severity and prognostic tool.²

Chronic hypertensive retinopathy is managed via systemic blood pressure control in coordination with primary care/cardiology, with routine ophthalmologic monitoring. Malignant hypertensive retinopathy is an ocular and systemic emergency requiring urgent, controlled (not overly rapid) blood pressure reduction coordinated with internal medicine, since too-rapid correction risks ischemic complications elsewhere in the body.²

• Fundus findings can be the first clue to previously undiagnosed or poorly controlled systemic hypertension
• Malignant hypertensive retinopathy is a hypertensive emergency — coordinate urgent, controlled BP management with internal medicine
• OCT macular structural change at presentation correlates with visual outcomes in malignant hypertensive retinopathy²
• Consider NAION as a rare cause of vision loss in a malignant hypertensive crisis, not just direct retinal vascular damage³
• Common pitfall: treating malignant hypertensive retinopathy as an isolated ocular finding rather than a systemic emergency
• Common pitfall: overly rapid BP correction risking ischemic complications